Eli Lilly's experimental weight loss drug, retatrutide, has demonstrated encouraging results in helping obese adults lose weight.
A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic. With ...
Zepbound is a dual-activating medication that combines glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like ...
Eli Lilly cut its 2024 revenue guidance, saying demand for its obesity and diabetes drugs had not met its lofty expectations.
Eli Lilly (LLY) shares traded down more than 6% Tuesday after the company reported revenue guidance for the fourth quarter of ...
A ROGUE pharmacist nicked supplies of weight loss wonder drug Ozempic from his dispensary’s stock room and flogged it on the ...
This could reduce the cost of Zepbound to $168 per month. Many health insurance plans don't cover the weight loss drug Zepbound because it's so new. It was approved by the FDA at the end of 2023 ...
A Bucks County woman is speaking out after her insurance company decided to no longer cover weight loss drugs.